Ophthotech Reports Second Quarter 2015 Financial and Operating Results

Go back to Ophthotech Reports Second Quarter 2015 Financial and Operating Results

UPDATE: Goldman Sachs Expects Underperformance at Ophthotech (OPHT), Cuts to Sell

August 7, 2015 7:02 AM EDT

(Updated - August 7, 2015 9:40 AM EDT)

Goldman Sachs downgraded Ophthotech Corp (NASDAQ: OPHT) from Neutral to Sell with a price target of $45 (unchanged). Analyst Terence Flynn expects share price underperformance due to competitor updates, as well as lack of meaningful catalysts.

"One of the tenants to our thesis has been potential future competition... More

Ophthotech Corp (OPHT) Misses Q2 EPS by 6c

August 5, 2015 7:34 AM EDT

Ophthotech Corp (NASDAQ: OPHT) reported Q2 EPS of ($1.08), $0.06 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.77 million.

For earnings history and earnings-related data on Ophthotech Corp (OPHT) click here.

... More